Canada markets close in 2 hours 28 minutes
  • S&P/TSX

    21,015.78
    -157.67 (-0.74%)
     
  • S&P 500

    4,581.20
    +6.41 (+0.14%)
     
  • DOW

    35,673.03
    -83.85 (-0.23%)
     
  • CAD/USD

    0.8109
    +0.0037 (+0.46%)
     
  • CRUDE OIL

    82.67
    -1.98 (-2.34%)
     
  • BTC-CAD

    72,928.47
    -4,233.42 (-5.49%)
     
  • CMC Crypto 200

    1,418.95
    -55.38 (-3.76%)
     
  • GOLD FUTURES

    1,797.60
    +4.20 (+0.23%)
     
  • RUSSELL 2000

    2,273.07
    -23.00 (-1.00%)
     
  • 10-Yr Bond

    1.5330
    -0.0860 (-5.31%)
     
  • NASDAQ

    15,356.20
    +120.48 (+0.79%)
     
  • VOLATILITY

    15.73
    -0.25 (-1.56%)
     
  • FTSE

    7,253.27
    -24.35 (-0.33%)
     
  • NIKKEI 225

    29,098.24
    -7.77 (-0.03%)
     
  • CAD/EUR

    0.6982
    +0.0025 (+0.36%)
     

U.S. FDA leaning toward approving Moderna half-dose booster -Bloomberg News

·1 min read
FILE PHOTO: Moderna COVID-19 vaccinations to Sarasota Hospital workers

(Reuters) -The U.S. Food and Drug Administration (FDA) is leaning toward authorizing half-dose booster shots of the Moderna Inc COVID-19 vaccine, Bloomberg News reported https://bloom.bg/3EXGHjA on Tuesday, citing people familiar with the matter.

The FDA had been seeking information about the effectiveness of a full third dose of the Moderna vaccine, but is now ready to move forward and consider the half-dose booster Moderna has proposed, the report said.

Moderna and the FDA did not immediately respond to Reuters request for comment outside regular business hours.

Moderna on Sept. 1 submitted its application to the U.S. Food and Drug Administration seeking authorization for a booster shot.

The original Moderna vaccine contains 100-micrograms of mRNA in each shot. The company's submission to regulators to authorize a half-dose booster would allow Moderna to produce more.

(Reporting by Akriti Sharma in Bengaluru; Editing by Muralikumar Anantharaman)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting